100 related articles for article (PubMed ID: 6756164)
1. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
[TBL] [Abstract][Full Text] [Related]
2. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
Saccà L; Orofino G; Petrone A; Vigorito C
J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by proinsulin of endogenous C-peptide release in healthy man.
Waldhäusl WK; Bratusch-Marrain P; Gasić S; Komjati M; Heding L
Am J Physiol; 1986 Aug; 251(2 Pt 1):E139-45. PubMed ID: 3526918
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans.
Meier JJ; Veldhuis JD; Butler PC
Diabetes; 2005 Jun; 54(6):1649-56. PubMed ID: 15919785
[TBL] [Abstract][Full Text] [Related]
5. Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.
Bratusch-Marrain PR; Waldhäusl WK; Gasić S; Hofer A
Metabolism; 1984 Feb; 33(2):151-7. PubMed ID: 6141519
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
[TBL] [Abstract][Full Text] [Related]
7. Suppression of basal, but not of glucose-stimulated insulin secretion by human insulin in healthy and obese hyperinsulinemic subjects.
Bratusch-Marrain PR; Waldhäusl WK
Metabolism; 1985 Feb; 34(2):188-93. PubMed ID: 3881650
[TBL] [Abstract][Full Text] [Related]
8. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the biological actions and pharmacokinetics of intravenously infused highly purified beef and biosynthetic human insulins in normal man.
Gray RS; Cowan P; Duncan LJ; Clarke BF
Diabete Metab; 1984 Sep; 10(3):188-93. PubMed ID: 6386558
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia.
DeFronzo RA; Binder C; Wahren J; Felig P; Ferrannini E; Faber OK
Acta Endocrinol (Copenh); 1981 Sep; 98(1):81-6. PubMed ID: 7025544
[TBL] [Abstract][Full Text] [Related]
11. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.
Waldhäusl W; Bratusch-Marrain P; Gasic S; Korn A; Nowotny P
Diabetologia; 1979 Oct; 17(4):221-7. PubMed ID: 499682
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects.
Massi-Benedetti M; Burrin JM; Capaldo B; Alberti KG
Diabetes Care; 1981; 4(2):163-7. PubMed ID: 7011718
[TBL] [Abstract][Full Text] [Related]
13. Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man.
Felig P; Wahren J
J Clin Invest; 1971 Aug; 50(8):1702-11. PubMed ID: 5097575
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.
Letiexhe MR; Scheen AJ; Gérard PL; Desaive C; Lefèbvre PJ
Int J Obes Relat Metab Disord; 1994 May; 18(5):295-300. PubMed ID: 8061722
[TBL] [Abstract][Full Text] [Related]
15. Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion.
Kraegen EW; Lazarus L; Campbell LV
Metabolism; 1983 Jun; 32(6):622-7. PubMed ID: 6341777
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
[TBL] [Abstract][Full Text] [Related]
17. Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.
Hovorka R; Koukkou E; Southerden D; Powrie JK; Young MA
Diabetologia; 1998 May; 41(5):548-54. PubMed ID: 9628272
[TBL] [Abstract][Full Text] [Related]
18. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
19. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
20. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
